Gpr17 receptor modulators
2013 M.P. Abbracchio, M.A. Battaglia, I. Eberini, M. Fumagalli, C. Parravicini, C. Sensi, P. Zaratin
Use of thiamphenicol for the treatment of chlamydia pneumoniae infections
2004 G.B. Colombo, D. Ungheri, L. Licciardello, M.R. Gismondo, L. Drago
Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections
2001 G.B. Colombo, D. Ungheri, L. Licciardello, L. Drago, M.R. Gismondo
Composition comprising probiotic bacteria for use in the treatment of immune disorders
2011 G. Mogna, G.P. Strozzi, L. Mogna, L. Drago
THREE-DIMENSIONAL SCAFFOLD CONSISTING OF FIBROIN AND POLYETHYLENE USEFUL FOR CELL CULTURES
2013 F. Cilurzo, P. Minghetti
Lupin-derived compounds having hypotensive activity and process for their production
2013 A. Arnoldi, G. Boschin, D. Resta, G. Scigliuolo
Biotechnologica sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
2012 D. Bianchi, M. Valetti, P. Bazza, N. Miraglia, E. Valoti
Shark-like chondroitin sulfate and process for the preparation thereof
2012 E. Valoti, N. Miraglia, D. Bianchi, M. Valetti, P. Bazza
Catalysts free from noble metals suitable for the electrochemical reduction of oxygen
2013 L. Formaro, M. Longhi, P. Messina, I. Galbiati
Catalysts free from noble metals suitable for the electrochemical reduction of oxygen
2013 L. Formaro, M. Longhi, P. Messina, I. Galbiati
CATALYSTS FREE FROM NOBLE METALS SUITABLE FOR THE ELECTROCHEMICAL REDUCTION OF OXYGEN
2013 L. Formaro, M. Longhi, P. Messina, I. Galbiati
Catalizzatori esenti da metalli preziosi adatti alla riduzione
2013 L. Formaro, M. Longhi, P. Messina, I. Galbiati
System for simultaing a manual interventional operation
2008 C. Cusano, I. Frosio, N.A. Borghese
Metallic fiber boards functionalized by catalysts and process for producing thereof
1999 L. Toia, C. Boffito, V. Ragaini, S. Vitali, C.L. Bianchi
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity
2005 A. Sparatore, D. Taramelli, N. Basilico, S. Parapini, F. Sparatore, V. Boido, C. Canu Boido
Biomarkers of resistance to infections in humans and biological applications thereof
2007 F. Veas, D. Misse, M. Clerici, D. Trabattoni
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
2005 M. Clerici, R. Bartholomew, D. Bray, E. Kandimalla, S. Agrawal
Markers for atherosclerosis
2005 D. Bray, M. Clerici, D. Trabattoni
Methods and compositions for the treatment of viral diseases
2009 F. Veas, D. Misse, D. Bray, M. Clerici
In vitro methods for assessing the susceptibility of HIV-1 infected individuals to cysteine-protease-mediated activation- induced programmed cell death
1997 P.A. Henkart, A. Sarin, M. Clerici, G.M. Shearer
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Patent497
Data di pubblicazione
- 2020 - 202670
- 2010 - 2019183
- 2000 - 2009201
- 1990 - 199937
- 1984 - 19896
Settore disciplinare
- Settore CHIM/06 - Chimica Organica75
- Settore CHIM/08 - Chimica Farmace...61
- Settore BIO/14 - Farmacologia42
- Settore CHIM/03 - Chimica General...38
- Settore CHIM/09 - Farmaceutico Te...26
- Settore INF/01 - Informatica25
- Settore AGR/15 - Scienze e Tecnol...24
- Settore CHIM/04 - Chimica Industr...23
- Settore BIO/10 - Biochimica22
- Settore MED/04 - Patologia Generale19
Keyword
- antibacterials3
- natural products3
- alzheimer's disease2
- amylase2
- avalanche rescue2
- controlled release2
- enzyme2
- folate2
- glycopeptides2
- hydrogen sulfide-releasing drug2
Accesso al fulltext
- no fulltext474
- reserved12
- open11
Progetto
- -2
- ESSENCE1
- NoPest1